Is Thyrocare a good company?
Thyrocare Technologies is rated 3.3 out of 5, based on 590 reviews by employees on AmbitionBox. Thyrocare Technologies is known for Skill development which is rated at the top and given a rating of 3.3. However, Career growth is rated the lowest at 2.8 and can be improved.
Why Thyrocare tests are so cheap?
Thyrocare tests and packages are cheap because of: Low-cost business model: Thyrocare works with a vast logistic network through its collection centres and home collection. Thus, they need not spend money on rental and infrastructure like shops. This reduces their operating expense.
What does Thyrocare Tech do?
Thyrocare Technologies Limited was incorporated in the year January 28 2000. The company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
Is thyrocare a good investment?
THYROCARE is one of the top 18% companies with good fundamentals !
What happened to thyrocare?
Thyrocare Technologies fell 6.5 percent on Monday after startup PharmEasy acquired a 66.1 percent stake in the company for Rs 4,546 crore. Thyrocare Technologies fell 6.5 percent on Monday after startup PharmEasy acquired a 66.1 percent stake in the company for Rs 4,546 crore.
Who founded thyrocare?
Arokiaswamy VelumaniThyrocare / Founder
What is future of thyrocare share?
If you are looking for stocks with good return, Thyrocare Technologies Limited stock can be a bad, high-risk 1-year investment option. Thyrocare Technologies Limited real time quote is equal to 618.250 INR at 2022-07-17, but your current investment may be devalued in the future. Get It Now!
Is Thyrocare a good investment?
India’s online pharmacy market is estimated to swell to $2.7 billion by 2023 from about $360 million in 2020. With the deal from PharmEasy, Thyrocare is no more a simple diagnostic centre, Tech + Diagnostic will help Thyrocare to achieve phenomenal growth in the coming years.
Why did PharmEasy buy Thyrocare?
At the time of announcing the deal, the company said that the collaboration between PharmEasy and Thyrocare would help accelerate the delivery of high-quality diagnostic and outpatient department (OPD) services across the full continuum of patient care to nearly 800 million Indians.
Is thyrocare reliable Quora?
Thyrocare is cheating lot of people’s by providing them wrong reports. They only know to play with words and don’t even check the samples. Please don’t go for thyrocare ever. A big fraud company.
Has Thyrocare been sold?
API Holdings, the parent firm of e-pharmacy PharmEasy, forked out Rs 4,546 crore for a controlling stake in diagnostics firm Thyrocare last week, becoming the first startup unicorn to acquire a listed legacy company in India.
Who is buying Thyrocare?
PharmEasy’s parent API Holdings recently announced the acquisition of a majority stake in Thyrocare for Rs 4,546 crore.
Is Thyrocare technologies a good buy?
What is future of Thyrocare share?